Continuous morphine infusion for end-stage lung cancer patients

Oncology Letters

Volumn 5, Issue 3, 2013, Pages 972-974

  Kim, Young Hak ^a   Okuda, Chiyuki ^a   Sakamori, Yuichi ^a   Masago, Katsuhiro ^a   Togashi, Yosuke ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Dyspnea; End stage; Intravenous; Lung cancer; Morphine; Pain; Subcutaneous

Indexed keywords

MORPHINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; COMORBIDITY; CONTINUOUS INFUSION; DISABILITY; DISEASE SEVERITY; DYSPNEA; END STAGE LIVER DISEASE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PAIN; RETROSPECTIVE STUDY; SURVIVAL RATE;

EID: 84872708556     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1101     Document Type: Article

References (8)

1. Qaseem A, Snow V, Shekelle P, Casey DE Jr, Cross JT Jr, Owens DK; Clinical Efficacy Assessment Subcommittee of the American College of Physicians; Dallas P, Dolan NC, ForcieaMA, Halasyamani L, Hopkins RH Jr and Shekelle P: Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148: 141-146, 2008.
2. Anderson SL and Shreve ST: Continuous subcutaneous infusion of opiates at end-of-life. Ann Pharmacother 38: 1015-1023, 2004.
3. Glare P, Walsh D, Groh E and Nelson KA: The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer. Am J Hosp Palliat Care 19: 343-350, 2002.
4. Kvale PA, Selecky PA and Prakash UB: Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines (2ndedition). Chest 132 (3 Suppl): 368S-403S, 2007.
5. Ben-Aharon I, Gafter-Gvili A, Paul M, Leibovici L and StemmerSM: Interventions for alleviating cancer-related dyspnea: a systematic review. J Clin Oncol 26: 2396-2404, 2008.
6. Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J and WongRK; Supportive Care Guidelines Groupof the Cancer Care Ontario Program in Evidence-Based Care: The management of dyspnea in cancer patients: a systematic review. Support Care Cancer 16: 329-337, 2008.
7. Nelson KA, Glare PA, Walsh D and Groh ES: A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manage 13: 262-267, 1997.
8. Mercadante S: Intravenous morphine for management of cancer pain. Lancet Oncol 11: 484-489, 2010.